Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study

Antonio González-Martı́n, Hyun Cheol Chung, Esma Saâda-Bouzid, Eduardo Yáñez, Hélène Senellart, Philippe A. Cassier, Bristi Basu, Bradley R. Corr, Eugenia Girda, Corina E. Dutcus, Chinyere E. Okpara, Razi Ghori, Fan Jin, Roman Groisberg, Zarnie Lwin